» Articles » PMID: 35008728

Blood Pressure Elevation of Tubular Specific (P)RR Transgenic Mice and Lethal Tubular Degeneration Due to Possible Intracellular Interactions Between (P)RR and Alternative Renin Products

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Jan 11
PMID 35008728
Authors
Affiliations
Soon will be listed here.
Abstract

The prorenin/renin receptor ((P)RR) is a multifunctional protein that is widely distributed in various organs. Despite intensive research for more than 20 years, this receptor has not been fully characterized. In this study, we generated mice overexpressing the tubular epithelial (P)RR gene ((P)RR-TG mice) to test the previously reported functional role of (P)RR by Ramkumar et al. in 2015 using tubular specific (P)RR KO mice. (P)RR-TG mice were maintained and analyzed in individual metabolic cages and were administered angiotensin II blocker (ARB), direct renin inhibitor (DRI), and bafilomycin, that is, vacuolar ATPase (V-ATPase) antagonist. (P)RR-TG mice were hypertensive and had alkalized urine with lower osmolality and Na excretion. ARB and DRI, but not bafilomycin, concurrently decreased blood pressure. Bafilomycin acidized urine of (P)RR-TG mice, or equivalently this phenomenon restored the effect of overexpressed transgene, suggesting that (P)RR functioned as a V-ATPase in renal tubules. Afterall, (P)RR-TG mice were mated with alternative renin transgenic mice (ARen2-TG), which we identified as intracellular renin previously, to generate double transgenic mice (DT-TG). Lethal renal tubular damage was observed in DT-TG mice, suggesting that intracellular renin may be a ligand for (P)RR in tubules. In summary, (P)RR did not substantially affect the tissue renin-angiotensin system (RAS) in our model of tubular specific (P)RR gene over-expression, but alternative intracellular renin may be involved in (P)RR signaling in addition to conventional V-ATPase function. Further investigations are warranted.

Citing Articles

Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.

Tang N, Cheng L, Hao J, Xu B, Pan X, Wei X Acta Neuropathol Commun. 2025; 13(1):45.

PMID: 40025578 PMC: 11871713. DOI: 10.1186/s40478-025-01965-6.


Functional Roles of Furin in Cardio-Cerebrovascular Diseases.

Wichaiyo S, Koonyosying P, Morales N ACS Pharmacol Transl Sci. 2024; 7(3):570-585.

PMID: 38481703 PMC: 10928904. DOI: 10.1021/acsptsci.3c00325.


Correlation between glycated hemoglobin A1c, urinary microalbumin, urinary creatinine, β2 microglobulin, retinol binding protein and diabetic retinopathy.

Song J, Han X, Chen J, Liu K World J Diabetes. 2023; 14(7):1103-1111.

PMID: 37547593 PMC: 10401450. DOI: 10.4239/wjd.v14.i7.1103.


(Pro)Renin Receptor Decoy Peptide PRO20 Protects against Oxidative Renal Damage Induced by Advanced Oxidation Protein Products.

Fang H, Yang T, Zhou B, Li X Molecules. 2023; 28(7).

PMID: 37049779 PMC: 10096258. DOI: 10.3390/molecules28073017.


How to select the lowest instrumented vertebra in NF-1 non-dystrophic scoliosis.

Shao X, Zhang T, Yang J, Deng Y, Huang Z, Yang J Eur Spine J. 2023; 32(4):1153-1160.

PMID: 36809342 DOI: 10.1007/s00586-023-07600-z.

References
1.
Pohl M, Kaminski H, Castrop H, Bader M, Himmerkus N, Bleich M . Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron. J Biol Chem. 2010; 285(53):41935-46. PMC: 3009920. DOI: 10.1074/jbc.M110.150284. View

2.
Ramkumar N, Stuart D, Calquin M, Quadri S, Wang S, van Hoek A . Nephron-specific deletion of the prorenin receptor causes a urine concentration defect. Am J Physiol Renal Physiol. 2015; 309(1):F48-56. PMC: 4490380. DOI: 10.1152/ajprenal.00126.2015. View

3.
Danser A . The Role of the (Pro)renin Receptor in Hypertensive Disease. Am J Hypertens. 2015; 28(10):1187-96. DOI: 10.1093/ajh/hpv045. View

4.
Hoffmann N, Peters J . Functions of the (pro)renin receptor (Atp6ap2) at molecular and system levels: pathological implications in hypertension, renal and brain development, inflammation, and fibrosis. Pharmacol Res. 2021; 173:105922. DOI: 10.1016/j.phrs.2021.105922. View

5.
Burckle C, Bader M . Prorenin and its ancient receptor. Hypertension. 2006; 48(4):549-51. DOI: 10.1161/01.HYP.0000241132.48495.df. View